← Back to Clinical Trials
Recruiting NCT05040711

NCT05040711 mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05040711
Status Recruiting
Phase
Sponsor Rutgers, The State University of New Jersey
Condition Caregiver Stress Syndrome
Study Type INTERVENTIONAL
Enrollment 162 participants
Start Date 2022-04-26
Primary Completion 2026-10-01

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindfulness CoachActive Comparator

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 162 participants in total. It began in 2022-04-26 with a primary completion date of 2026-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Older adults with serious illness and their caregivers have high rates of anxiety and limited access to effective, non-pharmacological treatments. A recent National Academy of Medicine report recommended increased emphasis on disseminating and implementing evidence-based psychotherapies in order to have maximal public health impact. Through this work, I will identify a sustainable and potentially scalable dyadic intervention and delivery model to manage symptoms of anxiety in older adults with serious illness and their caregivers in primary care.

Eligibility Criteria

Inclusion Criteria: * adults 60+ * Diagnosis of or caregiver for individual with serious illnesses (e.g., ESRD, Cancer, CHF, COPD, Liver Disease) * Hads-A \> 8 for patient or caregiver * Blessed\<6 * fluent in English * vision and hearing does not interfere with mobile device use * caregivers who must be 21+ * caregiver must identify as primary source of informal care for patient * Caregiver blessed \<6 * caregiver is fluent in English * Caregiver's vision and hearing does not interfere with mobile device use. Exclusion Criteria: * experience with mindfulness therapy in last 2 years * not fluent in English * vision or hearing that impairs use of mobile device * cognitive impairment more than 6 on Blessed.

Contact & Investigator

Central Contact

ELISSA KOZLOV, PhD

✉ elissa.kozlov@Rutgers.edu

📞 9147153012

Principal Investigator

Elissa Kozlov, PhD

PRINCIPAL INVESTIGATOR

Rutgers University

Frequently Asked Questions

Who can join the NCT05040711 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, studying Caregiver Stress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05040711 currently recruiting?

Yes, NCT05040711 is actively recruiting participants. Contact the research team at elissa.kozlov@Rutgers.edu for enrollment information.

Where is the NCT05040711 trial being conducted?

This trial is being conducted at Livingston, United States, Monroe, United States, New Brunswick, United States.

Who is sponsoring the NCT05040711 clinical trial?

NCT05040711 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Elissa Kozlov, PhD at Rutgers University. The trial plans to enroll 162 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology